Skip to main content

Generics

  • Sandoz relaunches biosimilars website

    NEW YORK — Generic drug maker Sandoz has relaunched a website to promote its biosimilars business.

  • Walgreens partners with Chicago Public Schools and city health department on Tdap vaccination project

    DEERFIELD, Ill. — Walgreens, Chicago Public Schools and the Chicago Department of Public Health are teaming up to help parents of students in grades 6 to 12 meet a new Illinois state requirement for Tdap vaccinations, which help to protect against whooping cough, the pharmacy operator announced Tuesday.

  • FDA approves Par's generic bupropion hydrochloride extended-release tablets

    WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a generic drug for depression made by Par Pharmaceutical Cos., the drug maker said Tuesday.

    Par announced the approval of bupropion hydrochloride extended-release tablets in the 300-mg strength. The drug is a generic version of GlaxoSmithKline's Wellbutrin XL and is used to treat major depressive disorder. The company already markets the generic drug in the 150-mg strength.

  • Southeast Asian generics market projected to grow

    KUALA LUMPUR, Malaysia — A variety of macroeconomic factors are driving growth in the generic drug market in Southeast Asia.

    According to CPhI, which is sponsoring the CPhI Southeast Asia Summit 2013 in Bangkok next month, the drug industry in the region is projected to grow to $3.9 billion by 2016, and macroeconomic factors, such as government policies, stable economies and growing population are driving generics.

  • Ads for Roxane Labs win national awards

    NEW ALBANY, Ohio — Advertisements for Roxane Labs made by Prism Marketing won three Aster Awards and an award from Healthcare Marketing Report, Prism said.

    In addition to Healthcare Marketing Report's Merit Award for social media, for Roxane's animated digital advertisement, Prism's ads for Roxane the Aster Awards' Gold Award for a total advertising campaign; a Silver Award for a website series; and a Silver Award for a magazine advertising series.

  • FDA raises generic drug user fees for 2014

    WASHINGTON — The U.S. Food and Drug Administration this past weekend announced new fee rates for fiscal year 2014, including the abbreviated new drug application fee.

  • IMS’ Long: State of Rx market

    LAS VEGAS — This year, generic drugs account for 83% of all drugs dispensed in the United States, and that figure is set to get even larger over the next few years. That was among the takeaways from IMS Health VP industry relations Doug Long’s presentation Sunday morning.

  • Express Scripts study: Anxiety medication use higher among caregivers

    ST. LOUIS — According to a new report released today by Express Scripts, the stress associated with providing unpaid care for a sick or disabled adult can create additional detrimental effects on the caregiver's health, leading to a 29% greater use of anti-anxiety medications compared with non-caregivers.

X
This ad will auto-close in 10 seconds